Stoneridge, Inc. (NYSE:SRI) Just Reported Earnings, And Analysts Cut Their Target Price

Yahoo

04-05-2025

It's been a pretty great week for Stoneridge, Inc. (NYSE:SRI) shareholders, with its shares surging 11% to US$4.38 in the week since its latest first-quarter results. Revenues of US$218m beat expectations by a respectable 2.6%, although statutory losses per share increased. Stoneridge lost US$0.26, which was 53% more than what the analysts had included in their models. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.
Our free stock report includes 3 warning signs investors should be aware of before investing in Stoneridge. Read for free now.
Taking into account the latest results, Stoneridge's twin analysts currently expect revenues in 2025 to be US$872.7m, approximately in line with the last 12 months. Per-share statutory losses are expected to explode, reaching US$0.39 per share. Before this earnings report, the analysts had been forecasting revenues of US$866.4m and earnings per share (EPS) of US$0.10 in 2025. While the analysts have made no real change to their revenue estimates, we can see that the consensus is now modelling a loss next year - a clear dip in sentiment compared to the previous outlook of a profit.
Check out our latest analysis for Stoneridge
The consensus price target fell 13% to US$14.00per share, with the analysts clearly concerned by ballooning losses.
One way to get more context on these forecasts is to look at how they compare to both past performance, and how other companies in the same industry are performing. These estimates imply that revenue is expected to slow, with a forecast annualised decline of 2.1% by the end of 2025. This indicates a significant reduction from annual growth of 7.5% over the last five years. By contrast, our data suggests that other companies (with analyst coverage) in the same industry are forecast to see their revenue grow 9.6% annually for the foreseeable future. So although its revenues are forecast to shrink, this cloud does not come with a silver lining - Stoneridge is expected to lag the wider industry.
The biggest low-light for us was that the forecasts for Stoneridge dropped from profits to a loss next year. Fortunately, the analysts also reconfirmed their revenue estimates, suggesting that it's tracking in line with expectations. Although our data does suggest that Stoneridge's revenue is expected to perform worse than the wider industry. The consensus price target fell measurably, with the analysts seemingly not reassured by the latest results, leading to a lower estimate of Stoneridge's future valuation.
With that said, the long-term trajectory of the company's earnings is a lot more important than next year. At least one analyst has provided forecasts out to 2026, which can be seen for free on our platform here.
And what about risks? Every company has them, and we've spotted 3 warning signs for Stoneridge (of which 2 are concerning!) you should know about.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.